Financial Results for the Fiscal Year Ended March 31, 201 ３
May 9, 2013
Exchange where listed: TSE

Name of listed company: TERUMO CORPORATION(URL http://www.terumo.com/): 4543: Yutaro Shintaku, President and Representative Director: Tetsuya Kumei, General Manager, Corporate Communication Dept.
: +81 / 3 -6742 -8550

Company code number
Representative:
Please address all communications toPhone
Adoption of U.S. accounting standards [Yes/No]: No

1. Consolidated Financial Highlights for the Year Ended March 2013
(From April 1, 2012 to March 31, 2013)(1) Consolidated financial results(Notes: The amounts shown below ignore values of less than a million yen)

Net sales(Millions of yen)

Year ended March, 2013
Year ended March, 2012
(Notes) Comprehensive income:Operating income%(Millions of yen)

Ordinary income%

Net income(Millions of yen)%

53,216 (15.6)
51,376
4.0(13.2)
59,164
63,04917.8
0.7
4.0
March 2013: 93,735million yen (294.9%) March 2012: 23,737million yen (-2.9%)
402,294
386,686

Net income per share

47,014
24,167

Net income per share,
fully diluted

Net income perstockholders'equity(Yen)%%%－
11.9－7.0
March 2012: 57million yen

7.0
10.6

13.2
16.3

(Yen)

247.60127.28March 2013: 176million yen

Year ended March, 2013
Year ended March, 2012
(Notes) Equity in earnings of affiliates:(Millions of yen)

Ordinary income
per total assets%

94.5(25.3)

Operatingincome per
Net sales(2) Consolidated financial position
Total assets
As at March 31, 2013
As at March 31, 2012
(Notes) Shareholders' equity:

Net assets

Equity ratio

Net assets per share(Millions of yen)

(Millions of yen)%(Yen)

771,032692,520

437,909352,53756.7
50.9

2,304.42
1,855.25

March 31, 2013: 437,557 million yen

March 31, 2012: 352,272 million yen(3) Consolidated statements of cash flows

Year ended March, 2013
Year ended March, 2012

Cash flows fromoperating activities

Cash flows frominvesting activities

Cash flows from financing
activities(Millions of yen)

(Millions of yen)

(Millions of yen)

(Millions of yen)

50,27056,200(31,293)(247,182)(22,340)
182,982

75,16573,793

Cash and cash equivalents,end of period

2. Dividends
Cash dividends per shareat fiscal year end

at 1st half end
Year ended March, 2012
Year ended March, 2013
Year ending March, 2014 (forecast)

total(Yen)

(Yen)

(Yen)

17.00
22.00
29.00

22.00
22.00
29.00

39.00
44.00
58.00

3. Consolidated Forecast for the Year Ending March 2014 (From April 1, 2013 to March 31, 2014)
Operating income

Net sales

Ordinary income

Net income
per share

Net income(Millions of yen)%

(Millions of yen)%

(Millions of yen)%

30,00015.7
70,000Year ending March, 2014
14.3
(Notes) Assumed exchange rate in FY2013: 1US$=95yen, 1Euro=123yen

6.4
31.528,500
67,50017.7
31.4

19,00042,00030.8(10.7)(Millions of yen)Half year ending September, 2013%

222,000
460,000(Yen)

100.06221.20Among the information that Terumo discloses, forecasts of financial performance on future projections contain potential risks and uncertainty since these areforecasts on projections made by Terumo based on limited information available at the moment of disclosure. Accordingly, it should be noted that actual results
may differ from those forecasts on projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic
conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.

14. Financial Statements(1) Consolidated balance sheet(Millions of yen)
As at March 31, 2012

As at March 31, 2013

AmountAmount(Assets)%

I Current assets

256,867

37.1%

ChangesAmount%286,955

37.2%%
30,087

Cash and deposits

78,767

78,201(566)

Noteｓ and accounts receivable-trade

91,80095,0083,208

Marchandise and finished goods

44,04454,346

10,301Work in process

6,629

9,265

2,635

Raw material and supplies

18,60621,568

2,961

Deferred tax assets

9,707

11,258

1,550

Other

8,552

18,528

9,975

Allowance for doubtful accounts(1,240)(1,220)

11.7%

20

II Noncurrent assets

435,65262.9%

483,770

62.8%

48,11711.0%

1. Property, plant and equipment

131,75419.0%

144,82418.8%

13,0699.9%

Buildings and structures

47,10848,966

1,858

Machinery, equipment and vehicles

38,431

46,366

7,934

Land

21,29821,827

528

Lease assets

1,447

704

(742)

Construction in progress

15,243

17,794

2,550

Other

8,225

9,165

940

2. Intangible assets

270,79039.1%

296,634

38.5%

25,843

Goodwill

138,809

149,322

10,512Customer-related assets

83,75890,706

6,948

Other

48,22256,604

3. Investments and other assets

33,106

4.8%

42,311

8,382
5.5%

9,204

Investment securities

20,38730,304

9,917

Deferred tax assets

6,996

5,153

(1,843)

Other

5,722

6,852

1,129

III Deferred assets
Total assets

2

9.5%

－－306

0.0%

306

692,520100.0%

771,032

100.0%

78,512

27.8%

11.3%

(Millions of yen)
As at March 31, 2012

As at March 31, 2013AmountAmount(Liabilities)
I%

Notes and accounts payable-trade33,92037,515

3,594

Short-term loans payable

60,00018,046(41,953)－3,762

3,762

423

277

(145)

Income taxes payable

11,8402,609(9,230)

Deferred tax liabilities

2335

12

Provision for bonuses

5,048

4,834

(214)

Provision for directors' bonuses
Notes and accounts payable-facilities
Asset retirement obligations

115,84415.0%%

157,997

Lease obligations

II%

Current liabilities

Current portion of long-term loans payable

22.8%

ChangesAmount(42,153)

127109

(18)

7,027

6,624

(403)

840

420(420)

Other

38,747

41,611

2,863

Noncurrent liabilities

181,984

Bonds payable

80,00080,000－Long-term loans payable

50,00078,712

28,712

999

439

(560)

Deferred tax liabilities

44,73649,659

4,922

Provision for retirement benefits

1,538

1,247

(290)

202

198

(3)

Lease obligations

Provision for directors' retirement benefits
Asset retirement obligations

26.3%

217,278

28.2%

35,293(26.7%)

19.4%

153

155

2

Other

4,354

6,865

2,510

Total liabilities

339,98249.1%

333,12243.2%(6,860)(2.0%)

I

Shareholders' equity

381,34555.1%

419,99954.5%

38,653

10.1%

Capital stock

38,716－

Capital surplus

52,103

52,103－Retained earnings

290,529

329,188

38,659

(3)

(9)

(5)

Treasury stockII

38,716

Accumulated other comprehensive income(29,073)

Valuation difference on available-for-sale securities
Deferred gains or losses on hedges
Foreign currency translation adjustment(4.2%)

2.3%

46,630

7,458

7,510

1－

(1)

(29,023)

III Minority interests

17,557(51)

10,099(160.4%)

39,122264

0.0%3520.0%

87

33.0%

Total net assets

352,53750.9%

437,90956.8%

85,372

24.2%

Total liabilities, net assets

692,520100.0%

771,032

100.0%

78,512

11.3%

3

(2) Consolidated statement of income(Millions of yen)
For the year ended

For the year ended

March 31, 2012

March 31, 2013

ChangesAmountAmountAmount%%%I

Net sales

386,686

100.0%

402,294

100.0%

15,607

4.0%

II

Cost of sales

182,04647.1%

196,605

48.9%

14,5588.0%

Gross profit

204,63952.9%

205,688

51.1%

1,049

0.5%

141,59036.6%

152,472

37.9%

10,881

7.7%

63,04916.3%

53,216

13.2%(9,832)(15.6%)

1,356

75.2%

III Selling, general and administrative expenses
Operating income
IV Non-operating income

V

Interest income

309

307

(2)

Dividends income

373

284

(89)

Royalty income

149124(24)

Foreign exchange profit

－

1,257

1,257

Equity in earnings of affiliates

57

176

119

Other914

1,804

0.5%

1,009

3,160

0.8%

95

Non-operating expenses
Interest expenses

738

1,303

Sales discounts

586

597

10

Foreign exchange losses

990－(990)

Loss on disposal of inventories

1,728

677

(1,051)

Other

1,644

Ordinary income

5,689

1.5%

59,164

15.3%

2,421

565

5,000

1.2%

51,376

12.8%

776

(688)

(12.1%)(7,787)(13.2%)

1,170

173.3%(9,252)(90.8%)

2,635

5.3%

(20,207)(79.5%)

22,842

94.3%

VI Extraordinary income
Gain on sales of noncurrent assets

224

77(146)

Reversal of loss on disaster

156－

(156)

Subsidy income

295

Gain on transfer of business

－875
675

0.2%

892

580
1,846

0.4%

892

VII Extraordinary expenses
Impairment loss

221－

Loss on disposal of noncurrent assets

239

543

(221)
303

Loss on sales of investment securities

1,562－(1,562)

Loss on valuation of investment securities

7,754－(7,754)

Loss on sales of golf club memberships

5－

(5)

Loss on valuation of golf club memberships

－

3

3

Environmental expenses

407

Income before income taxes
Income taxes-current

24,929

Income taxes-deferred495

Income before minority interests
Minority interests in income
Net income

4

10,1892.6%

49,64912.9%25,425

6.6%

24,224

6.3%

390

937

0.2%

52,285

13.0%

5,218

1.3%

47,067

11.7%

7,179
(1,961)(16)(17,750)(2,456)

57

0.0%

53

0.0%

(4)

(7.7%)

24,167

6.2%

47,014

11.7%

22,846

94.5%

(3) Consolidated statement of comprehensive income

I

Income before minority interests

II

Other comprehensive income(Millions of yen)
For the year ended

For the year ended

March 31, 2012

March 31, 2013

AmountAmount24,22447,067

Valuation difference on available-for-sale securities

1,868

7,510

Deferred gains or losses on hedges(3,609)(1)Foreign currency translation adjustments

1,251

39,157

Share of other comprehensive income of associates
accounted for using equity method2Comprehensive income(487)246,66823,737

93,73523,726

93,6471087

Attributable to:Shareholders of Terumo Corporation
Minority interests5(4) Statement of changes in net assets(Millions of yen)
Shareholders' equity
Year ended March 2012
Beginning of period
Changes during this fiscal year
Dividends from surplus
Net income
Retirement of treasury stock
Purchase of treasury stock
Changes of items other than shareholders' equity (net)Total changes during this fiscal yearEnding of period

Capital stock
38,716－38,716

Capital surplus

Retained earnings

59,030342,965(6,926)(6,645)24,167(69,957)(6,926)52,103

Valuation difference on
available-for-sale securities
Year ended March 2012
Beginning of period
Changes during this fiscal year
Dividends from surplus
Net income
Retirement of treasury stock
Purchase of treasury stock
Changes of items other than shareholders' equity (net)Total changes during this fiscal year
Ending of period(1,919)Treasury stock(76,879)

Shareholders'equity total
363,832(6,645)24,167(52,436)
290,529

76,884(8)(8)

76,875(3)

17,512
381,345

Accumulated other comprehensive income
Deferred gains or losses
Foreign currencytranslation
on hedges
adjustments
3,611(30,322)

Accumulated
other comprehensive
income total(28,630)

Minority
interests
254

Net assets
total
335,456(6,645)24,167

1,868
1,868
(51)

(3,609)(3,609)1(442)(442)(29,073)

10
10
264

(8)
(431)
17,080352,537

Accumulated
other comprehensive
income total(29,073)

Minority
interests
264

Net assets
total
352,537

1,298
1,298
(29,023)(Millions of yen)

Shareholders' equity
Year ended March 2013
Beginning of period
Changes during this fiscal year
Dividends from surplus
Net income
Retirement of treasury stock
Purchase of treasury stock
Changes of items other than shareholders' equity (net)Total changes during this fiscal year
Ending of period

Capital stock
38,716

Capital surplus

Retained earnings

52,103

290,529(3)

Shareholders'equity total
381,345(8,354)47,014－38,716(51)(8,354)47,01438,659329,188－
52,103

Valuation difference on
available-for-sale securities
Year ended March 2013
Beginning of period
IFRS Adjustment
Changes during this fiscal year
Dividends from surplus
Directors' bonuses
Net income
Retirement of treasury stock
Purchase of treasury stock
Changes of items other than shareholders' equity (net)Total changes during this fiscal year
Ending of period

Treasury stock

(5)

(5)

(5)
(9)

38,653419,999

Accumulated other comprehensive income
Deferred gains or losses
Foreign currency
on hedges
translation
adjustments
1(29,023)(8,354)47,014

7,510
7,510
7,458

(1)
(1)
-

6

39,122
39,12210,099

46,63046,63017,557

87
87
352

(5)
46,71885,372437,909(5) Consolidated statements of cash flows

I(Millions of yen)

For the year ended

For the year ended

March 31, 2012

March 31, 2013

AmountAmountNet cash provided by (used in) operating activities
Income before income taxes

49,64952,285

Depreciation and amortization

21,25924,601

Impairment loss
Amortization of goodwill

221－

7,576

7,952

Equity in (earnings) losses of affiliates

(57)

(176)

Increase(decrease) in provision for retirement benefits

144(534)

Increase(decrease) in provision for directors' retirement benefits

(383)

(3)

Increase(decrease) in allowance for doubtful accounts

522

(96)

Increase(decrease) in provision for directors' bonuses

(17)

(18)

Interest and dividends income

(683)

(591)

Interest expenses

738

1,303

Foreign exchange losses (gains)712(2,976)

Reversal of loss on disaster(156)－Subsidy income

(295)

(875)

Gain on transfer of business－(892)

Loss (gain ) on disposal of noncurrent assets

239

543

Loss (gain) on sales of noncurrent assets

(224)

(77)

Loss (gain) on sales of investment securities

1,562－

Loss (gain) on valuation of investment securities

7,754－

5－－

407

390

Loss (gain) on sales of golf club memberships
Loss on valuation of golf club memberships
Loss on environmental expenses

3

Decrease (increase) in notes and accounts receivable-trade(8,961)985

Decrease (increase) in inventories(7,369)(10,590)

288

3,925

Increase (decrease) in trade payable
Other, net
Subtotal

4,337

(78)

77,26875,078Interest and dividends income received

909

841

Interest expenses paid(675)(1,330)

Income taxes paid

(20,213)(24,321)

Settlement package paid

(1,383)－Subsidy income received

295

056,200

50,270Net cash provided by (used in) operating activities
II Net cash provided by (used in) investment activities
Payments into time deposits(6,262)(561)

Proceeds from withdrawal of time deposits

2,597

2,803

Purchase of property, plant and equipment(21,132)(25,715)

Proceeds from sales of property, plant and equipment
Purchase of intangible assets
Payment for ｐerformance to asset retirement obligations
Purchase of investment securities

296322(3,133)(6,759)

(560)

(420)

(3)

(1,074)

Proceeds from sales of investment securities

1,146

－

Capital expenditure for subsidiary's equity(220,078)

(956)

－

1,372

Proceeds from transfer of business
Other, net

(51)

(306)

(247,182)(31,293)

Proceeds from long-term loans payable

50,00028,612

Proceeds from issuance of bonds

80,000－－1,264

Net cash provided by (used in) investment activities
III Net cash provided by (used in) finacing activities

Increase in short-term loans payable
Decrease in short-term loans payable
Net increase (decrease) in short-term loans payable
Purchase of treasury stock
Repayments of financial lease obligations
Cash dividends paid
Net cash provided by (used in) finacing activities
IV Effect of exchange rate changes on cash and cash equivalents－(1,278)

60,000(42,000)(8)(5)(363)(579)(6,645)(8,354)

182,982(22,340)

(867)

4,735

V Net increase(decrease) in cash and cash equivalents(8,866)

1,371

VI Cash and cash equivalents at beginning of period

82,66073,793

VII Cash and cash equivalents at end of period

73,79375,1657

(6)Notes
Significant accounting policies in preparing the consolidated financial statements
Not applicable.

Changes in presentation
Relating to consolidated balance sheet"Derivatives" of current assets in previous consolidated account year is included in "Other" from current consolidated account year
due to becoming insignificant.
In order to reflect this change in presentation, consolidated balance sheet of previous consolidated account year is reclassified.
Consequently,"Derivatives" 9 million yen of current assets in previous consolidated account year is reclassified to "Other".

Additional Information
Not applicable.

85. Segment Information[Reportable Segments](1) Fiscal year ended March 31, 2012

(Millions of yen)
For the year ended
March 31, 2012

General HospitalBusiness

Cardiac &VascularBusiness

Blood
Management
Business

Subtotal

Adjustment

Total

Sales:
Sales to customer
Internal sales
Sales total

154,279

160,605

71,800386,686－－－－－－

386,686－

154,279

160,605

71,800386,686－386,686

Segment income (loss)

27,26730,796

3,515

61,5791,469

63,049Segment assets

156,350

198,664

258,109613,124

79,395692,520

6,658

5,101

9,232

20,994264

21,259

－

1,683

5,893

7,576

－

7,576

12,102

9,253

4,508

25,865755

26,620

Others:Depreciation and amortization
Amortization of goodwill
Net increase of tangible andintangible noncurrent assets

Notes:

1. Segment income is adjusted to be consistent with operating income shown on theconsolidated income statement.
2. Adjustment to segment income (loss), which amounted to 1,469 million yen, is the sumof (2,268) million yen for Inventories and 3,738 million yen for others.
3. Adjustment to segment assets, which amounted to 79,395 million yen, mainly includes
investments in"Cash and deposit", "Investments securities", "Deferred tax assets" andassets of the Administrative Department.
4. Depreciation of tangible fixed assets of the Company and its domestic consolidated
subsidiaries had been computed by declining-balance method , but effective from thisfiscal year, straight-line method has been applied to all tangible fixed assets.
Consequently, segment income increased 2,441 million yen in the General HospitalBusiness, 1,417 million yen in the Cardiac & Vascular Business, 387 million yen in the
Blood Management Business from the amounts that would have been posted under theprevious accounting method.

(2) Fiscal year ended March 31, 2013

(Millions of yen)
For the year ended
March 31, 2013

General HospitalBusiness

Cardiac &VascularBusiness

BloodManagementBusiness

Subtotal

Adjustment

Total

Sales and operating income:Sales to customer
Internal sales
Sales total

157,811

169,737

74,745402,294－－－－－－

402,294－

157,811

169,737

74,745402,294－402,294

Segment income

23,28023,6402,004

48,926

4,289

53,216

Segment assets

168,316

219,296308,322695,935

75,097771,032

Depreciation and amortization

7,765

5,890

10,47624,132468

24,601

Amortization of goodwill
Net increase of tangible andintangible noncurrent assets

－

1,767

6,184

7,952

－

7,952

12,794

12,8686,564

32,226935

33,162Others:

Notes:

1. Segment income is adjusted to be consistent with operating income shown on theconsolidated income statement.
2. Adjustment to segment income (loss), which amounted to 4,289 million yen, is the sumof 584 million yen for Inventories and 3,705 million yen for others.
3. Adjustment to segment assets, which amounted to 75,097 million yen, mainly includes
investments in"Cash and deposit", "Investments securities", "Deferred tax assets" andassets of the Administrative Department.

9(Note) Main products belonging to each business segment

Business segments

Main products

General Hospital business
Disposable medical devices and medical electronics

Syringes, Needles, Blood collection tubes, Solution sets, I.V.catheters,Infusion pumps, Syringe pumps, etc.

Pharmaceuticals

I.V.solutions, Nutritious food, Prefilled syringes, CAPD systems, etc.

Diabetes care products

Blood glucose monitoring systems

Consumer Healthcare business

Digital Thermometers, Blood pressure monitors, Blood glucose monitors (OTC), etc.

Cardiac and Vascular business
Interventional systems

Angiographic catheters, PTCA balloon catheters, Coronary stents, Neuro interventionalcoils, etc.

Cardiovascular systems

Oxygenerators, Cardio-pulmonary bypass system, LVA system, etc.

Vascular grafts

Artificial vascular grafts, Stent grafts

Blood Management business

Blood bags, Automated blood processing, Therapeutic aphaeresis, Cell therapy, etc.

(Supplementary Information)[Geographic Segments](1) Fiscal year ended March 31, 2012

(Millions of yen)
For the year ended
March 31, 2012

JapanEuropeAmericas

Asia and others

Total

Sales

190,469

71,76579,07045,381

386,686

Tangible noncurrent assets

96,9517,201

15,15012,451

131,754(2) Fiscal year ended March 31, 2013

(Millions of yen)
For the year ended
March 31, 2013

JapanEurope

Americas

Asia and others

Total

Sales

185,91375,39487,94053,045402,294

Tangible noncurrent assets

99,275

9,240

19,125

17,183

144,824

10